New AI chatbot aims to help smokers in poverty kick the habit

NCT ID NCT07620301

First seen Jun 10, 2026 · Last updated Jun 23, 2026 · Updated 1 time

Summary

This study will test a new multilingual chatbot called LIFT-UP designed to help people living in poverty quit smoking. Researchers will interview 22 adults who smoke at least 3 cigarettes daily and are motivated to quit. The goal is to see if the chatbot is easy to use and helpful, not yet to measure quit rates.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for SMOKING CESSATION are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Huntsman Cancer Institute/ University of Utah

    Salt Lake City, Utah, 84102, United States

    Contact

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

LIFT-UP Chatbot (behavioral intervention)

What this could lead to

If successful, this chatbot could provide an accessible, tailored tool to help underserved populations quit smoking.

What could go wrong

This is a very small, early-stage study (22 participants) focused on usability, not quitting success. The chatbot may not be effective or widely adopted.

Conditions

The condition(s) this trial relates to.

nicotine dependence Smoking Cessation

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.